Large numbers of surgically resected tissues and biopsy specimens are preserved as formalin-fixed and paraffin-embedded (FFPE) blocks. Therefore, FFPE tissues have been and still are the most abundant supply of clinical samples, which are often accompanied with sufficient follow-up data. Due to well-preserved morphology, FFPE is the standard process to handle post-mortem tissues which are very important sources of rare disease[@b1]. In addition, FFPE tissues also play an irreplaceable role in the fast growing translation medical research through bridging laboratory work and clinical applications. Full exploration of FFPE tissues is essential for medical research.

Unfortunately, the nucleic acids present extensive degradation in FFPE tissues and random fragmentation differs in normal and tumour tissues, making it more problematic to measure long RNA molecules. The average fragment length of DNA in FFPE tissues is often less than 300 bp, while the degradation of RNA is even worse due to the inherent instability as a single-stranded molecule[@b2]. In contrast, the degraded RNA cannot be restored like DNA using the other DNA strand as a template[@b1]. Due to these reasons, researchers prefer frozen tissues to FFPE tissues in long RNA exploration. Nonetheless, frozen tissues may not easily replace FFPE tissues because: (i) RNA degradation is unavoidable in archived snap-frozen tissues even though frozen clinical samples are considered to be well-preserved sources of nucleic acids[@b3]; (ii) a lack of sufficient clinical outcomes (e.g. prognosis and response to treatment) exists in the use of frozen tissues. Taken together, there is a pressing need to explore the possibility of RNA analysis in FFPE tissue.

Recently, the identification of abundant long non-coding RNAs (lncRNAs) (\> 200 bp in length) has catalysed their roles as drivers of tumour suppressive and oncogenic functions[@b4][@b5][@b6][@b7][@b8][@b9][@b10][@b11]. LncRNAs are a novel class of mRNA-like transcripts which represent the leading edge of cancer research. Their identity, function and dysregulation in various cancer types are beginning to be discovered. Increased research on these RNAs may lead to novel clinical applications in cancer biogenesis and prognosis. Unfortunately, the inherent instability of lncRNA makes the current studies mainly limited in frozen tissues[@b12].

Short RNA molecule fragments are stable and detectable in quantitative reverse-transcription PCR (quantitative RT-PCR)[@b13][@b14][@b15][@b16][@b17][@b18]. Meanwhile, previous studies have proved that amplicon size can affect the quantification of mRNA and smaller size can increase the yield of amplifiable mRNA[@b18][@b19][@b20][@b21]. However, the quantification reliability of such short amplicons in long-chain RNA molecules has not been systematically evaluated in FFPE tissues.

In this study, we investigated the possibility of long RNA quantification in FFPE tissues based on the broken molecular fragments. Inspired by previous studies, we selected 14 target RNAs (8 mRNAs and 6 lncRNAs) from literatures and designed short and long amplicons for each of them to evaluate the efficiency and reliability of quantifications in frozen and FFPE tissues. To address the problem of random fragmentation at different extents in tumour and normal tissues, we explored the expression profiles of long RNA quantification with 3 non-overlapping short amplicons in FFPE tissues from 65 patients with non-metastasis colorectal cancer (CRC).

Results
=======

Evaluation of amplification efficiency
--------------------------------------

Amplification efficiency is an important indicator that shows whether an amplicon works or not. To evaluate the quantification efficiency of short amplicons, parallel quantitative RT-PCR was initially performed with short-A and long amplicons on the mixed frozen and FFPE RNA samples to generate standard curves. The amplification efficiency and coefficient of determination (R^2^) of short and long amplicons are presented in [Table 1](#t1){ref-type="table"}. The results in [Fig. 1](#f1){ref-type="fig"} demonstrated that short amplicons were more efficient than long amplicons both in frozen (P = 0.0006) and FFPE tissues (P = 0.0152).

In frozen tissues, the short amplicon of the endogenous control *β-actin* had full amplification efficiency (100%) with R^2^ = 0.999, while 11 (79%) of 14 target RNAs achieved optimal efficiencies between 90% and 110% with R^2^ \> 0.960. In contrast, the amplification efficiency of long amplicons differed remarkably amongst different target RNAs, and only *SMAD4* reached the optimal efficiency. Additionally, the R^2^ of long amplicons was 0.885 ± 0.1 (Mean ± SD), which was significantly lower than that of short amplicons (0.990 ± 0.0, P \< 0.0001).

When it came to FFPE tissues, 11 (73%) of 15 short amplicons successfully achieved the optimal efficiencies between 90% and 110%, and the R^2^ of short amplicons was 0.957 ± 0.1 (Mean ± SD). In contrast, the amplification efficiency of most long amplicons was overblown, and even *β-actin* failed to achieve an optimal efficiency. The R^2^ of long amplicons was 0.577 ± 0.3 (Mean ± SD), which was significantly lower than that of short amplicons (0.957 ± 0.1, P \< 0.0001).

Evaluation of quantification correlation
----------------------------------------

To determine the quantification consistency with short amplicons, the expression profiles of the 14 target RNAs with short-A amplicons were examined in frozen tissues and compared with those of the paired long amplicons. [Figure 2A](#f2){ref-type="fig"} intuitively shows the mean Ct values of the studied RNAs. The results demonstrated that the mean Ct values of short amplicons were significantly lower than that of long amplicons (P \< 0.0001). Generally, short amplicons had 1.8 cycles less than that of long amplicons in quantitative RT-PCR, suggesting that short amplicons were more sensitive for the quantification in frozen tissues. Moreover, the short-A amplicons were evaluated in FFPE tissues from the exact CRC cases of aforementioned frozen tissues. The results presented in [Fig. 2B](#f2){ref-type="fig"} indicated that the Ct values of short amplicons did not show significantly difference between frozen and FFPE tissues (P = 0.1455), suggesting that short amplicons quantified effectively in FFPE tissues.

To test the validity of short amplicons in detecting the different expression patterns, the expression profiles of the target RNAs were generated with paired short and long amplicons in frozen and FFPE tissues. [Table 2](#t2){ref-type="table"} shows the relative expression levels of target RNAs in CRC tissues compared with their adjacent normal tissues. The quantification consistency between short and long amplicons was 64% in frozen tissues. Worse than this, the quantification consistency of short amplicons between frozen and FFPE tissues was only 36%. The results suggested that the quantification with a single short amplicon was unreliable.

Evaluation of quantification reliability
----------------------------------------

Considering that the aforementioned poor consistency might be caused by the random RNA fragmentation at different extent in tumour and normal tissues, primer sets for two additional short amplicons (short-B and C) were designed for each of the studied RNAs. Thereafter, quantitative RT-PCR with 3 non-overlapping short amplicons (short-A, B and C) was performed in 65 colorectal tumour-normal pairs of FFPE tissues, including 32 Dukes\' A and 33 Dukes\' B.

As [Fig. 3](#f3){ref-type="fig"} shows, a close relativity existed amongst 3 short amplicons. The correlation between the mean Ct values and individual short-A, B and C amplicon was 0.9386, 0.8437 and 0.9581, respectively. The correlation between the mean Ct values and short-B amplicon was much lower than that of the other two short amplicons, which was also reflected by the separate data points in [Fig. 3A](#f3){ref-type="fig"}. In the comparison of colorectal carcinomas with their adjacent normal tissues, the correlation between the mean fold change values and individual short-A, B and C amplicon was 0.9608, 0.9064 and 0.8874, respectively ([Figure 3B](#f3){ref-type="fig"}). As it can be seen from [Table 3](#t3){ref-type="table"}, 14 target RNAs showed a concordance of 57% on the fold change trends (regulation or no change) with 3 short amplicons, while the quantification consistency obtained from at least two short amplicons was 100%. The results demonstrated the possibility of long RNA analysis in FFPE tissues using 3 non-overlapping short amplicons.

Discussion
==========

FFPE tissues are important resources for biomedical research and play an irreplaceable role in translational medicine research. However, there exists extensive degradation of nucleic acids especially for long-chain RNA molecules, such as mRNA and lncRNA[@b12]. To explore the possibility of long RNA analysis in FFPE tissues, we evaluated the quantification efficiency and reliability of short amplicons. Our major discovery in this study is that we can obtain reliable quantification data of long-chain RNA from FFPE tissues by performing quantitative RT-PCR with 3 non-overlapping short amplicons, which makes it possible to study mRNA and lncRNA in FFPE tissues.

The effect of amplicon size on quantification has been revealed previously[@b18][@b19][@b20][@b21], however, in this study, we evaluated the effect in a more rigorous way. As we mentioned in primer design, the short amplicon and corresponding long amplicon shared a forward or a reverse primer sequence, therefore, the short amplicon was always a segment within the long amplicon. Our results indicated that short amplicons achieved optimal efficiency, however, most long amplicons had poor amplification efficiency both in frozen and FFPE tissues. In general, 90%--110% is considered to be the optimal efficiency. Lower efficiency of the amplicon suggests that the corresponding primer set barely work, while higher efficiency outside this range suggests possible PCR inhibition[@b22]. It shall be noted that most PCR procedures assume that the amplification efficiency for the amplicon of interest is constant and nearly 100%. Furthermore, the commonly used comparative Ct method even assumes equal efficiency in reference and target amplicons. However, such a comparative Ct method is very sensitive to variation in PCR efficiency[@b23]. The parameter R^2^ denotes the repeatability of efficiency, not only amongst triplicate samples of same diluted gradient, but also amongst serial dilution samples. The significantly higher R^2^ of short amplicon is a further proof of stable efficiency, which implies that the good amplification efficiency is maintained throughout different RNAs.

Short amplicons are more efficient than long amplicons in quantitative RT-PCR. The Ct value is the PCR cycle at which a statistically significant increase in target amplicon fluorescence can be detected above background. Our results indicated that short amplicons generally required 1.8 cycles less than that of long amplicons in frozen tissues. The smaller size has offered the possibility of higher sensitivity for short amplicons since shorter sequence will be less affected by the fragmentations. It is generally believed that long-chain RNA is often better preserved and less frequently broken in frozen tissues compared to FFPE tissues. Our results demonstrated that the Ct values obtained from the two types of tissues with short amplicons did not show significant differences. This implies that with short amplicons, FFPE and frozen tissues are promising to be used interchangeably in lncRNA and mRNA analysis by quantitative RT-PCR.

Random fragmentation of RNA to different extent in matched normal and tumour tissues compromised the quantification reliability of short amplicons. In our previous study[@b14], we used RNA integrity number (RIN) to measure the quality of snap-frozen RNA samples, and it turned out to be 7.3 ± 1.1 (Mean ± SD) in CRC tissues and 3.3 ± 1.6 (Mean ± SD) in adjacent normal tissues. The significant difference of RNA quality between normal and tumour samples also occurs in FFPE tissues. This could be due to the fact that RNase activity in CRC tissues is lower than that in normal tissues[@b24]. The fragmentation occurred in amplicon sequence or in primer sequence will cause the failure of amplification, and further lead to the poor quantification consistency. It is impossible to get the degradation ratio between tumour and normal tissues, and therefore, varying degrees of degradation might not be systematically corrected[@b3].

Using 3 non-overlapping short amplicons for one target RNA, we can reliably determine the expression profiles of lncRNA and mRNA in FFPE tissues by quantitative RT-PCR. Degradation of different extent in tumour and normal tissues is a troublesome problem in quantification. As such, using one amplicon, no matter long or short, cannot reliably validate the expression of a target RNA even in frozen tissues. Three short amplicons can address this problem and ultimately determine the expression profiles of target RNAs. Nevertheless, slight differences existed between our results and the published data for some of the RNA expression profiles. In the final analysis, there are 3 main reasons for the differences. First, for the previous reports, the quality of their studied RNA samples and the details of primer sets in quantitative RT-PCR are not available. As shown in this study, RNA integrity and primer design are two critical points to guarantee the quantification reliability. Second, some studies used cultured human CRC cells. The change of microenvironment *in vitro* might affect the RNA expression profile. Last but not the least, different stages of CRC would present different RNA expression profiles. Dukes\' A and B were selected in our study for screening lncRNAs and mRNAs related to tumorigenesis. In late stages of CRC, the differentially expressed RNAs may be more related to tumour metastasis. On the other hand, necrosis in late stage tumour tissues is more severe and brings about extensive RNA degradation.

A previous study on plasma-based lncRNA demonstrated significant difference in expression levels amongst different segments of *MALAT1*[@b13]. Likewise, short-B amplicon we designed for *MALAT1* seemed to be at a much lower expression level than short-A and C amplicons in CRC. The mechanism for this remained unclear. Further studies are needed to confirm the characteristics of short-B amplicon in *MALAT1*.

There still exists a limitation for the quantification of mRNA using short amplicons. One widely applied guideline for mRNA amplification is that the amplicon should span one or more introns to avoid possible interference from genomic DNA. However, since the primer set we designed only amplify a product of 50--70 bp, it is impossible to span introns unless the intron is short enough. For this point, short amplicons are not as good as long amplicons. Considering this, it is important to ensure there is no genomic DNA contamination in the RNA.

In conclusion, we have investigated a short-amplicon approach in quantitative RT-PCR to quantify lncRNA and mRNA in FFPE tissues. Our study shows that 3 non-overlapping short amplicons for one target RNA provide the possibility of long-chain RNA analysis in standardized- preserved FFPE tissues.

Methods
=======

Clinical specimens and study design
-----------------------------------

The study was approved by the Institutional Review Board of Shanghai Medical College in Fudan University, with written informed consent obtained from all patients. All experiments in this study were performed in accordance with the approved guidelines and regulations. Colorectal carcinomas with adjacent normal tissues, including 18 snap-frozen and 83 FFPE surgical specimens, were collected from Zhongshan and Huashan Hospitals in Fudan University between 2007 and 2013. For the CRC sample selection, routine histological classification was used according to the WHO classification of tumours[@b25]. All cases were diagnosed by two pathologists and independently reviewed by an expert CRC pathologist. Patients who had received preoperative radiotherapy or chemotherapy were excluded. [Supplementary Table S1](#s1){ref-type="supplementary-material"} summarizes the clinical characteristics of the patients and tumours in the study.

The study consisted of 3 different phases. All samples were allocated to the 3 phases without overlapping between any two phases ([Figure 4](#f4){ref-type="fig"}). In phase 1, the amplification efficiency of short and long amplicons was evaluated in 6 independent frozen and FFPE surgical colorectal tissues from 12 patients. To eliminate the possible interference from individual differences on the final results, the total RNA samples from the frozen and FFPE tissues were mixed, respectively. The standard curves on the 14 target RNAs and an endogenous control were generated in the mixed frozen and FFPE RNA samples using quantitative RT-PCR with paired short and long amplicons.

In phase 2, the quantification correlation between short and long amplicons was determined in paired frozen and FFPE surgical colorectal tissues from 12 patients. Manual macrodissection was performed on both frozen and FFPE tissues to ensure the presence of \> 75% cancer cells or normal epithelial cells. The expression profiles of the 14 target RNAs in the comparison of colorectal carcinomas with their adjacent normal tissues were assessed using quantitative RT-PCR with paired short and long amplicons.

In phase 3, the quantification reliability of 3 non-overlapping short amplicons was investigated on the 14 target RNAs in FFPE tissues from 65 non-metastasis CRC patients. The manual macrodissection was also performed as mentioned in the phase 2 before the RNA extraction. The expression profiles of the 14 target RNAs in the comparison of colorectal carcinomas with their adjacent normal tissues were determined using quantitative RT-PCR with 3 non-overlapping short amplicons.

Macrodissection
---------------

Macrodissection was essentially as described in our previous studies[@b15][@b16]. H&E-stained sections of each of the snap-frozen and FFPE tissue blocks were prepared to check the proportion of tumour material. If a tumour had more than 75% neoplastic cells, it was deemed suitable for analysis without further purification of tumour cells. If, however, histology showed the tumour having \< 75% cancer cells, it was selected and marked as tumour for manual macrodissection. Similarly, if histology showed the normal tissue having \< 75% epithelial cells, it was also selected and marked epithelial cells for manual macrodissection.

RNA isolation
-------------

Total RNA of the frozen tissue sections was extracted using the RNeasy Plus Mini Kit according to the instructions of the manufacturer (QIAGEN, Hilden, Germany). For the frozen tissues, genomic DNA was eliminated by the gDNA Eliminator spin column. Total RNA of the FFPE tissue sections was isolated using the RecoverAll Total Nucleic Acid Isolation Kit according to the instructions of the manufacturer (Ambion, Austin, Texas, USA). For the FFPE tissues, DNase digestion to the nucleic acid samples was included before the final purification of RNA. The concentration of RNA sample was quantified by NanoDrop 2000 Spectrophotometers (Thermo Fisher Scientific, Waltham, MA, USA). The quality of RNA sample was determined by OD 260/280 ratio. A RNA sample was discarded for further analysis if OD 260/280 ratio was less than 1.8.

Target RNA selection and primer design
--------------------------------------

Fourteen tumour-related long chain RNAs were selected as target molecules from literatures[@b6][@b7][@b8][@b9][@b10][@b11][@b15][@b26][@b27][@b28][@b29][@b30][@b31][@b32][@b33][@b34], including 8 mRNAs (*CDK6, JUN, MAPK3, PDGFRA, PDGFRB, PIK3R3, SMAD3, SMAD4*) and 6 lncRNAs (*DD3, H19, MALAT1, MEG3, p15AS, UCA1*). *β-actin* mRNA was used as an endogenous control in quantitative RT-PCR. [Supplementary Table S2a and S2b](#s1){ref-type="supplementary-material"} present the primer sequences and transcript variants of the target RNAs, respectively.

Two groups of primer sets were designed to amplify RNA short (\~60 bp, short-A) and long (\~200 bp) segments within the target sequences. For each of the target RNAs, the paired primer sets for the short and long amplicons shared either a forward or a reverse primer sequence. Such primer design ensured that the resulting short amplicon was always a segment of the long amplicon. Furthermore, additional primer sets were design to amplify other two short-amplicons (short-B and short-C) for each of the target RNAs. All 3 short amplicons were non-overlapping, arbitrarily chosen segments within the RNA sequence.

All the primer sets were designed in line with the general principles, and all splice variants were targeted for the amplification. The primer specificity was screened by performing BLAST using the Human genomic plus transcript database (Human G+T) and further verified through melting curve obtained in quantitative RT-PCR. [Supplementary Figure S3](#s1){ref-type="supplementary-material"} shows the melting curves on all the investigated primers. The primers were synthetized by Sangon Biotech (Shanghai, China) and the purification was performed by high affinity purification.

Quantitative RT-PCR
-------------------

Following the 'Minimal Information for Publication of Quantitative Real-Time PCR Experiments' (MIQE) guidelines, quantitative RT-PCR of the 14 target RNAs and *β-actin* gene was performed on 7900HT Fast Real-Time PCR System (Applied Biosystems) using High Capacity cDNA Reverse Transcription Kit (Invitrogen, Foster City, California, USA) and Power SYBR Green PCR Master Mix (Applied Biosystems, Warrington, UK) according to the instructions of manufacturers.

For the reverse transcription, 500 ng of total RNA sample was reverse transcripted into cDNA by the random primers in a total volume of 50 μl. For real-time PCR, 6 μl of the cDNA solution was amplified with 16 μl 2X SYBR Green mix and 2 μl target-specific primers (5 μM/L) in a final volume of 32 μl. All assays were carried out in triplicate. The Ct values were determined using 40 cycles.

Statistical analysis
--------------------

The amplification efficiency and coefficient of determination (R^2^) of an amplicon were generated from standard curve. Amplification efficiency was calculated using the equation: E = 10^-1/k^-1 in which E is the amplification efficiency and k is the slope of standard curve. Mann-Whitney unpaired test was used to determine the significant difference of amplification efficiency between short and long amplicons.

Target RNA expression level was normalized to *β-actin* gene. The relative RNA expression between tumour and normal samples was calculated using the equation: ΔCt = Ct (target) -Ct (β-actin); ΔΔCt = ΔCt (tumour) -ΔCt (normal); Fold change was calculated using the equation: Folds = 2^-ΔΔCt^. Wilcoxon test for paired samples was used to determine the significant difference of target RNA expression level between colorectal carcinomas and their adjacent normal tissues. The target RNA was considered as being up-regulated if the fold change exceeded 2.0 or as being down-regulated if the fold change was below 0.5. The fold change between 0.5 and 2.0 was defined as unchanged. MedCalc software (version 10.4.7.0; MedCalc, Mariakerke, Belgium) was used to perform the statistical analysis. All P values were two-tailed, with P value \< 0.05 considered significantly different.
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![Box-and-whisker plots of amplification efficiency and coefficient of determination (R^2^) obtained from short and long amplicons both in frozen and FFPE tissues.\
(a): Box-and-whisker plot of amplification efficiency. (b): Box-and-whisker plot of coefficient of determination (R^2^). Frozen-short A: quantification with short-A amplicons in frozen tissues. Frozen-long: quantification with long amplicons in frozen tissues. FFPE-short A: quantification with short-A amplicons in FFPE tissues. FFPE-long: quantification with long amplicons in FFPE tissues.](srep07246-f1){#f1}

![Comparisons of Ct values obtained from short and long amplicons in frozen and FFPE tissues.\
(a): Comparison of Ct values obtained from short and long amplicons in frozen tissues. (b): Comparison of Ct values obtained from short amplicons in frozen and FFPE tissues. Frozen-short A: quantification with short-A amplicons in frozen tissues. FFPE-short A: quantification with short-A amplicons in FFPE tissues. Error bars indicate the SD of the Ct values.](srep07246-f2){#f2}

![Correlation of Ct values and fold changes obtained from 3 non-overlapping short amplicons in FFPE tissues.\
(a): Correlation of Ct values obtained from 3 non-overlapping short amplicons in 65 FFPE colorectal surgical tissues. (b): Correlation of fold changes (tumour/normal) obtained from 3 non-overlapping short amplicons in 65 FFPE colorectal surgical tissues. Mean Ct values of 3 short amplicons for each target RNA were calculated by individual sample.](srep07246-f3){#f3}

![Study design.\
FFPE: formalin-fixed, paraffin-embedded; RT-PCR: reverse transcriptase polymerase chain reaction. Long amplicon: long segments about 200 bp within the target RNA sequence. Short amplicon: short segments about 60 bp within the target RNA sequence.](srep07246-f4){#f4}

###### Amplification Efficiency of Short and Long Amplicons in Frozen and FFPE tissues

                            Frozen tissue   FFPE tissue                                                                    
  ------------------------ --------------- ------------- ------------- ------------- ----------- ----------- ------------- -------------
  **Endogenous control**                                                                                                          
  β-actin                        100            129          0.999         0.907         101         204         1.000         0.775
  **Target RNA**                                                                                                                  
  DD3                            107            169          0.973         0.904         109         111         0.962         0.631
  H19                            105            163          0.999         0.852         106        2840         0.993         0.208
  MALAT1                         106            198          0.999         0.731         105         371         1.000         0.414
  MEG3                           100            135          0.988         0.892         111         618         0.983         0.521
  p15AS                          139            174          0.966         0.761         114         287         0.699         0.826
  UCA1                           158            249          0.985         0.877         271         -98         0.969         0.207
  CDK6                           106            221          0.988         0.798         96          -62         0.972         0.656
  JUN                            108            118          0.999         0.952         106         315         0.998         0.636
  MAPK3                          98             87           0.999         0.981         99          168         0.968         0.887
  PDGFRA                         107            141          0.999         0.897         102         525         0.996         0.46
  PDGFRB                         108            117          0.999         0.979         118         222         0.985         0.844
  PIK3R3                         103            215          0.962         0.782         110         -98         0.926         0.048
  SMAD3                          113            115          0.994         0.976         110         154         0.978         0.700
  SMAD4                          101            109          0.994         0.984         107         202         0.935         0.845
  Mean ± SD                   111 ± 0.2      156 ± 0.5    0.990 ± 0.0   0.885 ± 0.1   118 ± 0.4   384 ± 7.1   0.957 ± 0.1   0.577 ± 0.3
  P value                      0.0006                      \< 0.0001                   0.0152                  \< 0.0001          

###### Quantification Correlation of Short and Long Amplicons in Frozen and FFPE Tissues

                 Frozen tissue   FFPE tissue   Correlation                                                    
  ------------- --------------- ------------- ------------- ------- ------ ------ ------- ------ ------ ----- -----
  DD3                0.001           0.1          Down       0.009   0.2    Down   0.519   1.0     0     \+    \-
  H19                0.016           5.2           Up        0.012   2.2     Up    0.001   20.3    Up    \+    \+
  MALAT1             0.001           0.1          Down       0.001   0.2    Down   0.052   0.8     0     \+    \-
  MEG3               0.001           0.1          Down       0.151   0.8     0     0.970   0.9     0     \-    \-
  p15AS              0.002           0.2          Down       0.003   0.1    Down   0.791   1.0     0     \+    \-
  UCA1               0.034           4.1           Up        0.003   20.4    Up    0.034   12.7    Up    \+    \+
  CDK6               0.850           1.1            0        0.266   3.1     0     0.129   2.0     0     \+    \+
  JUN                0.001           0.3          Down       0.034   1.3     0     0.233   0.7     0     \-    \-
  MAPK3              0.001           0.3          Down       0.012   0.6     0     0.001   0.4    Down   \-    \+
  PDGFRA             0.001           0.4          Down       0.850   2.8     0     0.016   0.6     0     \-    \-
  PDGFRB             0.034           1.4            0        0.970   0.7     0     0.001   3.3     Up    \+    \-
  PIK3R3             0.470           0.6            0        0.820   0.8     0     0.151   1.1     0     \+    \+
  SMAD3              0.001           0.3          Down       0.001   0.2    Down   0.021   0.6     0     \+    \-
  SMAD4              0.034           0.3          Down       0.233   2.6     0     0.970   0.9     0     \-    \-
  Correlation                                                                                            64%   36%

\*, tumour/normal tissue; +, correlated; -, uncorrelated; Up, Up-regulated; Down, down-regulated; 0, unchanged.

###### Quantification Reliability of Short Amplicons in FFPE tissue

  RNA                        Short-A amplicon   Short-B amplicon   Short-C amplicon   Correlation                                            
  ------------- ----------- ------------------ ------------------ ------------------ ------------- ------ ------ ------- ----- ------ ------ -----
  DD3            Dukes\' A        0.519               1.2                 0              0.507      2.3     0     0.035   2.5    Up     \+    \-
                 Dukes\' B        0.038               0.8                 0              0.647      1.7     0     0.019   2.3    Up     \+    \-
  H19            Dukes\' A        0.000               14.7                Up             0.000      12.6    Up    0.000   3.5    Up     \+    \+
                 Dukes\' B        0.000               13.8                Up             0.000      61.8    Up    0.000   7.6    Up     \+    \+
  MALAT1         Dukes\' A        0.874               1.0                 0              0.175      0.9     0     0.000   0.6    0      \+    \+
                 Dukes\' B        0.001               0.6                 0              0.001      0.6     0     0.038   0.9    0      \+    \+
  MEG3           Dukes\' A        0.258               0.8                 0              0.041      0.6     0     0.016   0.8    0      \+    \+
                 Dukes\' B        0.231               1.0                 0              0.228      0.8     0     0.056   0.9    0      \+    \+
  p15AS          Dukes\' A        0.001               2.5                 Up             0.035      1.7     0     0.001   2.0    Up     \+    \-
                 Dukes\' B        0.004               1.3                 0              0.018      2.1     Up    0.011   2.4    Up     \+    \-
  UCA1           Dukes\' A        0.000               10.0                Up             0.000      11.2    Up    0.000   8.5    Up     \+    \+
                 Dukes\' B        0.000               5.6                 Up             0.000      8.2     Up    0.000   7.0    Up     \+    \+
  CDK6           Dukes\' A        0.003               2.1                 Up             0.002      3.7     Up    0.009   1.8    0      \+    \-
                 Dukes\' B        0.040               1.5                 0              0.047      1.7     0     0.143   1.4    0      \+    \+
  JUN            Dukes\' A        0.308               0.8                 0              0.003      0.7     0     0.000   0.5   Down    \+    \-
                 Dukes\' B        0.006               0.7                 0              0.000      0.4    Down   0.000   0.5   Down    \+    \-
  MAPK3          Dukes\' A        0.041               0.8                 0              0.000      0.5    Down   0.001   0.7    0      \+    \-
                 Dukes\' B        0.011               0.8                 0              0.000      0.5    Down   0.058   0.7    0      \+    \-
  PDGFRA         Dukes\' A        0.001               0.7                 0              0.000      0.6     0     0.026   0.9    0      \+    \+
                 Dukes\' B        0.000               0.6                 0              0.000      0.8     0     0.006   0.7    0      \+    \+
  PDGFRB         Dukes\' A        0.000               1.7                 0              0.001      2.1     Up    0.000   2.3    Up     \+    \-
                 Dukes\' B        0.003               1.1                 0              0.001      1.4     0     0.000   2.2    Up     \+    \-
  PIK3R3         Dukes\' A        0.005               2.6                 Up             0.031      1.4     0     0.000   2.5    Up     \+    \-
                 Dukes\' B        0.002               1.3                 0              0.129      1.2     0     0.000   1.6    0      \+    \+
  SMAD3          Dukes\' A        0.717               1.1                 0              0.091      0.9     0     0.914   1.1    0      \+    \+
                 Dukes\' B        0.681               0.6                 0              0.006      0.7     0     0.943   1.1    0      \+    \+
  SMAD4          Dukes\' A        0.993               1.0                 0              0.948      1.2     0     0.235   1.3    0      \+    \+
                 Dukes\' B        0.071               0.9                 0              0.008      0.8     0     0.102   0.6    0      \+    \+
  Correlation                                                                                                                          100%   57%

\*, tumour/normal tissue; +, correlated; -, uncorrelated; Up, Up-regulated; Down, down-regulated; 0, unchanged.
